{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05897099",
            "orgStudyIdInfo": {
                "id": "20230061"
            },
            "secondaryIdInfos": [
                {
                    "id": "R01DA058352",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/R01DA058352"
                }
            ],
            "organization": {
                "fullName": "University of Miami",
                "class": "OTHER"
            },
            "briefTitle": "Comprehensive HIV and Harm Prevention Via Telehealth",
            "officialTitle": "Comprehensive HIV and Harm Prevention Via Telehealth: CHARIOT, a Randomized Controlled Trial",
            "acronym": "CHARIOT",
            "therapeuticArea": [
                "Infectious Diseases"
            ],
            "study": "comprehensive-hiv-and-harm-prevention-via-telehealth"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-08-01",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-03-09",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-10-09",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-06-01",
            "studyFirstSubmitQcDate": "2023-06-01",
            "studyFirstPostDateStruct": {
                "date": "2023-06-09",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-13",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-17",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Hansel Tookes",
                "investigatorTitle": "Associate Professor",
                "investigatorAffiliation": "University of Miami"
            },
            "leadSponsor": {
                "name": "University of Miami",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Institute on Drug Abuse (NIDA)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to test 2 different ways to offer medications to prevent human immunodeficiency virus (HIV), cure hepatitis C virus (HCV) (if applicable) and treat substance use disorder (if desired) in people who inject drugs."
        },
        "conditionsModule": {
            "conditions": [
                "HIV Infections"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "PREVENTION",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 350,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Comprehensive Tele-harm Reduction",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will have enhanced access to a physician and clinical psychologist via remote video technology wherever the participant is located and prefers engagement (SSP, home, shelter, encampment). Participants will be in this group for 12 months.",
                    "interventionNames": [
                        "Behavioral: Comprehensive Tele-harm Reduction"
                    ]
                },
                {
                    "label": "Off-site Linkage to HIV prevention",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Participants in this group will receive off-site linkage to HIV care by having case management/social work services through our community engagement team. Participants will be in this group for 12 months.",
                    "interventionNames": [
                        "Behavioral: Off-site Linkage to HIV Prevention"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BEHAVIORAL",
                    "name": "Comprehensive Tele-harm Reduction",
                    "description": "Comprehensive Tele-Harm Reduction is on-demand services including low-barrier access to PrEP, medications for substance use disorder and hepatitis C treatment. It includes mobile phlebotomy, peer harm reduction counseling, medication management, telehealth mental health/substance use disorder services-- all delivered via an syringe services program.",
                    "armGroupLabels": [
                        "Comprehensive Tele-harm Reduction"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "Off-site Linkage to HIV Prevention",
                    "description": "The community engagement team is comprised of peers and social workers and provides the wraparound support needed.The team will assist participants in scheduling appointments at community health clinics. The community engagement team provides active clinic referral- that is, a member of the team will accompany patients to the first clinic visit.",
                    "armGroupLabels": [
                        "Off-site Linkage to HIV prevention"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "HIV prevention via pre-exposure prophylaxis (PrEP)",
                    "description": "Intracellular levels of tenofovir diphosphate (TFV-DP) by DBS or cabotegravir injection in previous 8 weeks by electronic health record abstraction",
                    "timeFrame": "up to 12 months"
                },
                {
                    "measure": "HIV prevention via medications for opioid use disorder",
                    "description": "Norbuprenorphine or methadone on urine drug screen; or naltrexone or buprenorphine extended-release injection in previous 4 weeks by electronic health record abstraction",
                    "timeFrame": "up to 12 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "syringe coverage",
                    "description": "Number of syringes distributed/(number of injections per day x days between exchanges)",
                    "timeFrame": "up to 12 months"
                },
                {
                    "measure": "PrEP Adherence",
                    "description": "TFV-DP level of 700 fmol/punch on DBS for Truvada; TFV-DP level of 950 fmol/punch on DBS for Descovy",
                    "timeFrame": "up to 12 months"
                },
                {
                    "measure": "Engagement in HCV treatment",
                    "description": "Direct acting antiviral prescription confirmed on electronic health record abstraction",
                    "timeFrame": "Up to 12 months"
                },
                {
                    "measure": "HCV cure",
                    "description": "Negative HCV RNA viral load at least 12 weeks post treatment completion",
                    "timeFrame": "up to 12 months"
                },
                {
                    "measure": "treatment of sexually transmitted infections",
                    "description": "Medical records show prescription of appropriate antibiotics",
                    "timeFrame": "up to 12 months"
                },
                {
                    "measure": "time to harm",
                    "description": "Time to: (1) emergency department visit or hospitalization for injection-related infection or overdose; (2) incident HIV infection; (3) incident HCV infection; or (4) death from overdose",
                    "timeFrame": "up to 12 months"
                },
                {
                    "measure": "number of harms",
                    "description": "Count of (1) emergency department visit or hospitalization for injection-related infection or overdose; (2) incident HIV infection; (3) incident HCV infection; or (4) death from overdose",
                    "timeFrame": "up to 12 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* age 18 or older\n* able to speak English or Spanish\n* willing and able to sign informed consent, provide locator information and medical records release\n* non-reactive result on rapid HIV test\n* use of SSP to exchange syringes 2 times in the past 3 months\n* planning to stay in the area for 12 months\n\nExclusion Criteria:\n\n* reactive HIV test\n* currently on medications for opioid use disorder (MOUD) by urine drug screen\n* currently on PrEP by self-report\n* Principal or site investigator discretion\n* currently in prison or jail\n* current enrollment in Clinical Trials Network 121\n* receipt of tele-harm reduction in previous 3 months\n* signs or symptoms of acute HIV infection",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Hansel Tookes, MD",
                    "role": "CONTACT",
                    "phone": "3052431615",
                    "email": "hetookes@med.miami.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Hansel Tookes, MD",
                    "affiliation": "University of Miami",
                    "role": "PRINCIPAL_INVESTIGATOR"
                },
                {
                    "name": "Tyler Bartholomew, PhD",
                    "affiliation": "University of Miami",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "IDEA Syringe Services Program",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33136",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Hansel Tookes, MD",
                            "role": "CONTACT",
                            "phone": "305-243-1615",
                            "email": "hetookes@med.miami.edu"
                        },
                        {
                            "role": "CONTACT",
                            "phoneExt": "Tookes",
                            "email": "hetookes@med.miami.edu"
                        },
                        {
                            "name": "Hansel Tookes, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Tyler Bartholomew, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000015658",
                    "term": "HIV Infections"
                }
            ],
            "ancestors": [
                {
                    "id": "D000086982",
                    "term": "Blood-Borne Infections"
                },
                {
                    "id": "D000003141",
                    "term": "Communicable Diseases"
                },
                {
                    "id": "D000007239",
                    "term": "Infections"
                },
                {
                    "id": "D000015229",
                    "term": "Sexually Transmitted Diseases, Viral"
                },
                {
                    "id": "D000012749",
                    "term": "Sexually Transmitted Diseases"
                },
                {
                    "id": "D000016180",
                    "term": "Lentivirus Infections"
                },
                {
                    "id": "D000012192",
                    "term": "Retroviridae Infections"
                },
                {
                    "id": "D000012327",
                    "term": "RNA Virus Infections"
                },
                {
                    "id": "D000014777",
                    "term": "Virus Diseases"
                },
                {
                    "id": "D000091662",
                    "term": "Genital Diseases"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000007153",
                    "term": "Immunologic Deficiency Syndromes"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3522",
                    "name": "Acquired Immunodeficiency Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M18250",
                    "name": "HIV Infections",
                    "asFound": "HIV Infections",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10283",
                    "name": "Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2593",
                    "name": "Blood-Borne Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M15558",
                    "name": "Sexually Transmitted Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17933",
                    "name": "Sexually Transmitted Diseases, Viral",
                    "relevance": "LOW"
                },
                {
                    "id": "M18640",
                    "name": "Lentivirus Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M15026",
                    "name": "Retroviridae Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M17522",
                    "name": "Virus Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15149",
                    "name": "RNA Virus Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M2876",
                    "name": "Genital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M10199",
                    "name": "Immunologic Deficiency Syndromes",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        }
    },
    "hasResults": false
}